![Louise Rodino-Klapac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 975 059 $ in data 31/05/2026
Fondatrice di Myonexus Therapeutics, Inc., Louise Rodino-Klapac è nel consiglio di Alliance for Regenerative Medicine e Aavantibio, Inc. e Chief Scientific Officer & Executive VP presso Sarepta Therapeutics, Inc., membro della American Academy of Neurology e membro della American Society of Gene & Cell Therapy. In precedenza ha occupato la posizione di Chief Scientific Officer presso Myonexus Therapeutics, Inc. e Head-Laboratory for Gene Therapy Research al Nationwide Children's Hospital. Si è laureata al King's College (Pennsylvania) e ha conseguito un dottorato alla Ohio State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2026 | 54.564 ( 0,05% ) | 975 059 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 14/12/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direttore/Membro del Consiglio | 01/01/2021 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Corporate Officer/Principal | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Nationwide Children's Hospital
 Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Corporate Officer/Principal | 01/06/2019 |
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Fondatore | 01/04/2019 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Nationwide Children's Hospital
Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Health Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
